SCHEMBL6500208

SCHEMBL6500208

CCN(Nc1ccccn1)C(=O)c1ccc(C(=O)O)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 3/20 0.44
PKM P14618 3/20 0.44
POLB P06746 1/20 0.44
NPC1 O15118 6/20 0.40
RAB9A P51151 6/20 0.40
KMT2A Q03164 3/20 0.40
MITF O75030 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
HTT P42858 2/20 0.39
MAPK1 P28482 1/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HPGD P15428 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6495013 0.90 NPC1 (0.41) ALDH1A1PKMNPC1RAB9AKMT2A
SCHEMBL6495564 0.73 ITGAV (0.55)
SCHEMBL23867580 0.70 CYP2C19 (0.41) ALDH1A1PKMNPC1RAB9AKMT2A
SCHEMBL6500201 0.69 KMT2A (0.48) KDM4EALDH1A1PKMPOLBNPC1
SCHEMBL29049272 0.65 RAB9A (0.49) PKMPOLBNPC1RAB9AKMT2A
SCHEMBL28601923 0.65 GAA (0.45) ALDH1A1PKMPOLBNPC1RAB9A
Alcohol SCHEMBL28943550 0.64 DAO (0.60) KDM4EALDH1A1PKMPOLBRAB9A
SCHEMBL5327831 0.64 DAO (0.43) KDM4EALDH1A1PKMNPC1RAB9A
SCHEMBL31039816 0.63 LCK (0.63) KDM4EALDH1A1NPC1RAB9AKMT2A
SCHEMBL4254787 0.63 LCK (0.63) KDM4EALDH1A1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6960594-B2 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer SHIRE BIOCHEM INC. (CA) 2005-11-01 US disclosed
US-20020137947-A1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer BIOCHEM PHARMA INC. 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137947-A1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer ITGB5, ITGB2, ITGA2 KDM4E 601/4885ALDH1A1 1056/4885PKM 4279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.